President Barack Obama will present University of California, San Diego bioengineering Professor Shu Chien with the National Medal of Science in a White House ceremony Oct. 21 at 2 p.m. EST (11 a.m. PST). The ceremony will be carried live by satellite feed and webcast on the White House website at: http://www.whitehouse.gov/live.
Men are funnier than women, but only just barely and mostly to other men. So says a psychology study from the University of California, San Diego Division of Social Sciences.
Every year, millions of patients undergo lifesaving surgeries. The outcome of each procedure is driven by dynamic factors such as the patient’s health, drugs and instruments used, team communication, and the wisdom of the surgeon’s hand. To advance safety and innovation in today’s operating rooms, the School of Medicine at the University of California, San Diego has unveiled the Center for the Future of Surgery (CFoS) ─ the largest state-of-the art facility in the nation dedicated to catalyzing novel surgical technologies, techniques and teaching methods.
Men who took 400 international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention (SELECT) Trial. The results appeared Oct. 12 in the Journal of the American Medical Association.
A study by researchers at the University of California, San Diego School of Medicine suggests that differences in brain activation in individuals with a low level of response to alcohol may contribute to their inability to recognize modest levels of alcohol intoxication. Their findings could provide the potential to identify individuals who are at risk for developing an alcohol-use disorder before it develops – in essence, providing a marker for this vulnerability.
A collaborative partnership between the UC San Diego Liver Center and Antiviral Research Center (AVRC) has resulted in 19 clinical trials for hepatitis C virus (HCV), focused on developing more effective and well-tolerated HCV treatments.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
